Page 1 of Clinical Trials for "Valrubicin", 9 Total Matches
- 1TerminatedLast Updated: February 14, 2012Condition(s): Carcinoma in Situ; Transitional Cell Carcinoma; Non-muscle Invasive Bladder Cancer
- 2Not yet recruitingLast Updated: May 24, 2012Condition(s): Urothelial Carcinoma
- 3CompletedLast Updated: March 16, 2011Condition(s): Carcinoma in Situ; Bladder Cancer
- 4Active, not recruitingLast Updated: February 6, 2009Condition(s): Bladder Cancer
- 5CompletedLast Updated: February 6, 2009Condition(s): Bladder Cancer
- 6CompletedLast Updated: June 6, 2009Condition(s): Bladder Cancer
- 7Not yet recruitingLast Updated: May 4, 2012Condition(s): Transitional Cell Carcinoma; Bladder Cancer; Carcinoma in Situ; Carcinoma in Situ Concurrent With Papillary Tumors
- 8TerminatedLast Updated: February 14, 2012Condition(s): Bladder Cancer; CIS
- 9CompletedLast Updated: October 10, 2011Condition(s): Carcinoma in Situ of Bladder
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Valrubicin%22
